Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 222-884-9 | CAS number: 3648-20-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
Data source
Reference
- Reference Type:
- publication
- Title:
- Di(isononyl) Phthalate (DINP) and Di(isodecyl) Phthalate (DIDP) Are Not Mutagenic
- Author:
- Mckee R H
- Year:
- 2 000
- Bibliographic source:
- J. Appl. Toxicol. 20, 491–497 (2000)
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- not specified
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.12 (Mutagenicity - In Vivo Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- not specified
- GLP compliance:
- not specified
- Remarks:
- (this information was not provided)
- Type of assay:
- mammalian erythrocyte micronucleus test
Test material
- Reference substance name:
- 1,2-Benzenedicarboxylic acid, di-C9-11-branched alkyl esters, C10-rich
- EC Number:
- 271-091-4
- EC Name:
- 1,2-Benzenedicarboxylic acid, di-C9-11-branched alkyl esters, C10-rich
- Cas Number:
- 68515-49-1
- IUPAC Name:
- bis(8-methylnonyl) phthalate
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- CD-1
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories, Portage, MI
- Age at study initiation: 6-9 weeks
- Weight at study initiation: 17-35 g
- Housing: husbandry was consistent with the recommendations of the National Institute of Health (NIH), 1985.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: corn oil
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
No information - Duration of treatment / exposure:
- single dose 1 day
- Frequency of treatment:
- Once
- Post exposure period:
- 24, 48 and 72 hours (killing times)
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0 mg/kg bw/day (actual dose received)
- Remarks:
- (vehicle control)
- Dose / conc.:
- 1 250 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 2 500 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 5 000 mg/kg bw/day (actual dose received)
- No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- cyclophosphamide. 5 males and 5 females. Killing time: 24 h post administration
- Route of administration: oral, gavage
- Doses / concentrations: 20 mg/kg
Examinations
- Tissues and cell types examined:
- Bone marrow erythrocytes cells (from both femora)
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION:
A range-finding study was used to select doses for the definitive test, but, because there was no evidence of toxicity, the highest dose was 5 g/kg based on TSCA (Toxic Substances Control Act) guidelines (US EPA 798.5395).
TREATMENT AND SAMPLING TIMES:
Both femurs were removed from each treated mouse and the proximal ends were cut to expose the bone marrow, which was then aspirated with fetal bovine serum into a centrifuge tube. The cells were collected by centrifugation and slides were prepared.
DETAILS OF SLIDE PREPARATION:
After fixation in methanol, the slides were stained with acridine orange for ca. 1–2 min.
METHOD OF ANALYSIS:
Slides were evaluated at 400 X by fluorescence microscopy.
A total of 1000 erythrocytes were counted from each animal, and the total numbers of polychromatic (PCE) and normochromatic (NCE) erythrocytes were tabulated. A total of 1000 PCEs were evaluated for the presence of micronuclei. - Statistics:
- Statistical analysis included means and standard deviations of the micronucleus test data, and a test of equality of means was performed by standard one-way analysis of variance (Snedecor G., 1989).
Because the only statistically significant differences were between the positive and negative control groups, no additional statistical analysis was carried out.
Results and discussion
Test results
- Key result
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
There was no evidence of toxicity up to the highest dose tested.
RESULTS OF DEFINITIVE STUDY
- Mortality: All animals survived.
- Signs of toxicity: there was no evidence of toxicity.
- Induction of micronuclei (for Micronucleus assay): There were no significant differences between treatment groups and controls for either male or female mice at any dose or collection time.
- Ratio of PCE/NCE (for Micronucleus assay): The ratio of PCE/NCE remained unaffected by the treatment and was statistically not different from the control values.
- Positive control: Treatment with cyclophosphamide, the positive control, induced a significant increase in micronuclei in both males and females, confirming the adequacy of the testing procedure.
Any other information on results incl. tables
Table 1. In vivo micronucleus evaluation of DIDP (68515–49–1) in male CD-1 mice a
Treatment |
Dose |
Harvest time (h) |
% Micronucleated PCEs (1000 per animal) |
Ratio PCE/NCE mean ± S.E. |
|||
Males |
Females |
Total |
Males |
Females |
|||
Vehicle control (corn oil) |
10 ml kg-1 |
24 |
0.06 ± 0.04 |
0.04 ± 0.02 |
0.05 ± 0.02 |
0.67 ± 0.31 |
0.58 ± 0.18 |
|
|
48 |
0.00 ± 0.00 |
0.04 ± 0.02 |
0.02 ± 0.01 |
0.59 ± 0.08 |
1.00 ± 0.08 |
|
|
72 |
0.08 ± 0.04 |
0.02 ± 0.02 |
0.05 ± 0.02 |
0.89 ± 0.17 |
1.09 ± 0.13 |
Positive control |
|
24 |
2.04 ± 0.34* |
1.76 ± 0.28* |
1.90 ± 0.21* |
0.50 ± 0.12 |
0.48 ± 0.08 |
DIDP dose |
1250 mg kg-1 |
24 |
0.16 ± 0.04 |
0.10 ± 0.05 |
0.13 ± 0.03 |
0.35 ± 0.08 |
0.97 ± 0.09 |
|
|
48 |
0.06 ± 0.02 |
0.06 ± 0.04 |
0.06 ± 0.02 |
0.69 ± 0.14 |
1.15 ± 0.10 |
|
|
72 |
0.02 ± 0.02 |
0.10 ± 0.04 |
0.06 ± 0.03 |
0.79 ± 0.15 |
1.10 ± 0.14 |
|
2500 mg kg-1 |
24 |
0.08 ± 0.04 |
0.08 ± 0.04 |
0.08 ± 0.02 |
0.49 ± 0.08 |
0.83 ± 0.19 |
|
|
48 |
0.02 ± 0.02 |
0.06 ± 0.02 |
0.04 ± 0.02 |
0.91 ± 0.16 |
1.00 ± 0.15 |
|
|
72 |
0.04 ± 0.02 |
0.00 ± 0.00 |
0.02 ± 0.01 |
0.62 ± 0.16 |
0.96 ± 0.11 |
|
5000 mg kg-1 |
24 |
0.08 ± 0.04 |
0.06 ± 0.02 |
0.07 ± 0.02 |
0.38 ± 0.05 |
1.05 ± 0.17 |
|
|
48 |
0.00 ± 0.00 |
0.02 ± 0.02 |
0.01 ± 0.01 |
0.90 ± 0.10 |
1.02 ± 0.17 |
|
|
72 |
0.02 ± 0.02 |
0.06 ± 0.04 |
0.04 ± 0.02 |
0.89 ± 0.03 |
1.27 ± 0.19 |
a Values are means ± SEM; *significantly greater than the corresponding vehicle control (P < 0.05).
PCE = polychromatic erythrocyte; NCE = normochromatic erythrocyte
Applicant's summary and conclusion
- Conclusions:
- DIDP was determined to be not mutagenic in the mammalian erythrocyte micronucleus test.
- Executive summary:
An in-vivo micronucleus test was performed with Di(isodecyl) Phthalate (DIDP) according to OECD guideline 474 and EU method B.12. Five mice per sex and per group were exposed once (single dose) to test item diluted in corn oil at doses of 0 (vehicle control), 1250, 2500 and 5000 mg/kg bw, based on preliminary results. Animals were killed 24, 48 and 72 hours after administration of the test compound. Cyclophosphamide was used as a positive control (5 mice per sex at 20 mg/kg and killed 24 h post treatment). For each animal, bone marrow was extracted from both femora and the slides were prepared for erythrocyte micronuclei observation. There were no significant differences between treatment groups and controls for either male or female mice at any dose or collection time. The ratio of PCE/NCE remained unaffected by the treatment and was statistically not different from the control values. Based on these results, DIDP was determined to be not mutagenic in the mammalian erythrocyte micronucleus test.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
